{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:19:02Z","timestamp":1787584742350,"version":"build-2736575974"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008386","name":"Marmara University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008386","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Osteoporos"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>\n                      <jats:italic>Summary<\/jats:italic>\n                    <\/jats:title>\n                    <jats:p>This nationwide study assessed clinical features of\u00a0osteoporosis in Turkish adults with diabetes. Osteoporosis prevalence was 9.36% in type 1 diabetes and 19.13% in type 2 diabetes, with higher rates in women and older individuals. Although overall fracture prevalence was low, fractures were markedly more frequent in patients with osteoporosis. Despite the high burden, most patients did not receive osteoporosis therapy, and age, female sex, and vascular complications were independently associated with osteoporosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>Fragility fractures related to diabetes are increasing worldwide with rising life expectancy. We aimed to investigate the prevalence of osteoporosis and its associated factors in a large nationwide cohort of adults with type 1 (T1DM) and type 2 diabetes (T2DM) in T\u00fcrkiye.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using Turkish Ministry of Health electronic health records (2015\u20132021), adults with T1DM and T2DM were identified and classified according to the presence or absence of osteoporosis. Demographics, comorbidities, diabetes-related complications, fracture diagnoses, and laboratory parameters were analyzed. Factors independently associated with osteoporosis were evaluated using multivariable logistic regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The cohort included 76,742 individuals with T1DM (mean age 44.3\u2009\u00b1\u200919.1\u00a0years; 45.8% women) and 7,006,910 with T2DM (mean age 59.1\u2009\u00b1\u200913.4\u00a0years; 60.2% women). Overall osteoporosis prevalence was 19.03% and was 9.3% in T1DM and 19.1% in T2DM. Osteoporosis was more frequent in women than men (T1DM: 14.17% vs 5.29% p\u2009&lt;\u20090.001; T2DM: 27.76% vs 6.04% p\u2009&lt;\u20090.001) and increased with age in both diabetes types. Fractures occurred in 0.22% of patients with T1DM and 0.21% of those with T2DM. In T1DM, fracture frequency was approximately sixfold higher in patients with osteoporosis than in those without osteoporosis (RR \u2248 6.92; 95% CI 5.09\u20139.39; p\u2009&lt;\u20090.001), whereas in T2DM osteoporosis was associated with an approximately fourfold higher fracture frequency (RR \u2248 3.98). Macrovascular and microvascular complications were more frequent among osteoporosis patients with T1DM than those with T2DM. Only 13.4% of patients with osteoporosis received pharmacological osteoporosis therapy. In multivariable analysis, older age (OR 1.06), female sex (OR 6.58), cardiovascular disease (OR 1.58), and microvascular complications (OR 1.38) were independently associated with osteoporosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In this nationwide Turkish cohort, osteoporosis affected 9.36% of adults with T1DM and 19.13% of those with T2DM. Among patients with osteoporosis, vascular complications were more prevalent in T1DM than in T2DM.Despite the substantial disease burden and the markedly higher fracture frequency in individuals with osteoporosis, most patients remained untreated.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11657-026-01677-x","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T01:19:03Z","timestamp":1771895943000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical features of osteoporosis in patients with type 1 and type 2 diabetes in T\u00fcrkiye: A nationwide study"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0075-6313","authenticated-orcid":false,"given":"Dilek Gogas","family":"Yavuz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6866-2364","authenticated-orcid":false,"given":"Cem","family":"Haymana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1531-0004","authenticated-orcid":false,"given":"Tolga","family":"Akkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1041-6881","authenticated-orcid":false,"given":"Muhiddin","family":"Yalcin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6003-0485","authenticated-orcid":false,"given":"Zeliha","family":"Hekimsoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0936-2476","authenticated-orcid":false,"given":"Ilker","family":"Tasci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3588-2256","authenticated-orcid":false,"given":"Mehmet Ali","family":"Eren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6947-2821","authenticated-orcid":false,"given":"Naim","family":"Ata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8104-6198","authenticated-orcid":false,"given":"Suayip","family":"Birinci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9309-7715","authenticated-orcid":false,"given":"Alper","family":"Sonmez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9637-6744","authenticated-orcid":false,"given":"Fahri","family":"Bayram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,24]]},"reference":[{"issue":"12","key":"1677_CR1","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1007\/s00198-018-4650-2","volume":"29","author":"SL Ferrari","year":"2018","unstructured":"Ferrari SL, Abrahamsen B, Napoli N et al (2018) Diagnosis and management of bone fragility in diabetes: an emerging challenge. Osteoporos Int 29(12):2585\u20132596. https:\/\/doi.org\/10.1007\/s00198-018-4650-2","journal-title":"Osteoporos Int"},{"issue":"3","key":"1677_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2022.101779","volume":"36","author":"NH Rasmussen","year":"2022","unstructured":"Rasmussen NH, Vestergaard P (2022) Diabetes and osteoporosis \u2013 treating two entities: a challenge or cause for concern? Best Pract Res Clin Rheumatol 36(3):101779. https:\/\/doi.org\/10.1016\/j.berh.2022.101779","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"1677_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2020.115457","volume":"137","author":"T Vilaca","year":"2020","unstructured":"Vilaca T, Schini M, Harnan S et al (2020) The risk of hip and non-vertebral fractures in type 1 and type 2 diabetes: a systematic review and meta-analysis update. Bone 137:115457. https:\/\/doi.org\/10.1016\/j.bone.2020.115457","journal-title":"Bone"},{"key":"1677_CR4","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/nrendo.2016.153","volume":"13","author":"N Napoli","year":"2017","unstructured":"Napoli N, Chandran M, Pierroz DD et al (2017) Mechanisms of diabetes mellitus induced bone fragility. Nat Rev Endocrinol 13:208\u2013219. https:\/\/doi.org\/10.1038\/nrendo.2016.153","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"1677_CR5","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.ecl.2021.03.005","volume":"50","author":"GI Schacter","year":"2021","unstructured":"Schacter GI, Leslie WD (2021) Diabetes and osteoporosis: Part I, epidemiology and pathophysiology. Endocrinol Metab Clin North Am 50(2):275\u2013285. https:\/\/doi.org\/10.1016\/j.ecl.2021.03.005","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"4","key":"1677_CR6","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1359\/jbmr.070102","volume":"22","author":"P Vestergaard","year":"2007","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L (2007) Diabetes and its complications and risk of fractures. J Bone Miner Res 22(4):573\u2013581. https:\/\/doi.org\/10.1359\/jbmr.070102","journal-title":"J Bone Miner Res"},{"issue":"16","key":"1677_CR7","doi-asserted-by":"publisher","first-page":"e19762","DOI":"10.1097\/MD.0000000000019762","volume":"99","author":"Y Si","year":"2020","unstructured":"Si Y, Wang C, Guo Y et al (2020) Prevalence of osteoporosis in patients with type 2 diabetes mellitus in the Chinese mainland: a protocol of systematic review and meta-analysis. Medicine (Baltimore) 99(16):e19762. https:\/\/doi.org\/10.1097\/MD.0000000000019762","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"1677_CR8","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1210\/jc.2011-3361","volume":"97","author":"AC Looker","year":"2012","unstructured":"Looker AC, Borrud LG, Dawson-Hughes B et al (2012) Osteoporosis or low bone mass at the femur neck or lumbar spine in older adults: United States, 2005\u20132008. J Clin Endocrinol Metab 97(6):1832\u20131839. https:\/\/doi.org\/10.1210\/jc.2011-3361","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1677_CR9","doi-asserted-by":"publisher","first-page":"511","DOI":"10.5144\/0256-4947.2007.511","volume":"27","author":"M Sadat-Ali","year":"2007","unstructured":"Sadat-Ali M, Al-Habdan IM, Al-Turki HA et al (2007) Bone mineral density among postmenopausal Saudi women. Ann Saudi Med 27(6):511\u2013514. https:\/\/doi.org\/10.5144\/0256-4947.2007.511","journal-title":"Ann Saudi Med"},{"key":"1677_CR10","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s40200-016-0269-1","volume":"15","author":"M Mojibian","year":"2016","unstructured":"Mojibian M, Sohrabi Z, Eshraghian MR et al (2016) Prevalence of osteoporosis and its risk factors in diabetic patients compared to the normal population. J Diabetes Metab Disord 15:46. https:\/\/doi.org\/10.1186\/s40200-016-0269-1","journal-title":"J Diabetes Metab Disord"},{"issue":"4","key":"1677_CR11","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/MED.0000000000000640","volume":"28","author":"R Pal","year":"2021","unstructured":"Pal R, Bhadada SK (2021) Bone health in diabetes: Indian perspective. Curr Opin Endocrinol Diabetes Obes 28(4):383\u2013389. https:\/\/doi.org\/10.1097\/MED.0000000000000640","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"1","key":"1677_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-022-01260-8","volume":"23","author":"X Liu","year":"2023","unstructured":"Liu X, Chen F, Liu L et al (2023) Prevalence of osteoporosis in patients with diabetes mellitus: a systematic review and meta-analysis of observational studies. BMC Endocr Disord 23(1):1. https:\/\/doi.org\/10.1186\/s12902-022-01260-8","journal-title":"BMC Endocr Disord"},{"issue":"8","key":"1677_CR13","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1002\/jbmr.XXXX","volume":"29","author":"G Leidig-Bruckner","year":"2014","unstructured":"Leidig-Bruckner G, Ziegler R, Scheidt-Nave C et al (2014) Prevalence of osteoporosis in patients with type 2 diabetes in Europe: a multicenter study. J Bone Miner Res 29(8):1805\u20131812. https:\/\/doi.org\/10.1002\/jbmr.XXXX","journal-title":"J Bone Miner Res"},{"issue":"5","key":"1677_CR14","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1111\/j.1365-2265.2011.04194.x","volume":"75","author":"P Vestergaard","year":"2011","unstructured":"Vestergaard P (2011) Diabetes and bone health. Clin Endocrinol Oxf 75(5):613\u2013620. https:\/\/doi.org\/10.1111\/j.1365-2265.2011.04194.x","journal-title":"Clin Endocrinol Oxf"},{"issue":"7","key":"1677_CR15","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1002\/jbmr.2310","volume":"29","author":"J Compston","year":"2014","unstructured":"Compston J, Cooper A, Cooper C et al (2014) Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK. J Bone Miner Res 29(7):1443\u20131457. https:\/\/doi.org\/10.1002\/jbmr.2310","journal-title":"J Bone Miner Res"},{"issue":"12","key":"1677_CR16","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1007\/s00198-014-2878-9","volume":"25","author":"JH Kim","year":"2014","unstructured":"Kim JH, Choi HJ, Ku EJ et al (2014) Trabecular bone score as an additional parameter in predicting osteoporotic fracture risk in postmenopausal women: the Korean Urban Rural Elderly cohort study. Osteoporos Int 25(12):2873\u20132879. https:\/\/doi.org\/10.1007\/s00198-014-2878-9","journal-title":"Osteoporos Int"},{"key":"1677_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6823-14-33","volume":"14","author":"G Leidig-Bruckner","year":"2014","unstructured":"Leidig-Bruckner G, Grobholz S, Bruckner T et al (2014) Prevalence and determinants of osteoporosis in patients with type 1 and type 2 diabetes mellitus. BMC Endocr Disord 14:33. https:\/\/doi.org\/10.1186\/1472-6823-14-33","journal-title":"BMC Endocr Disord"},{"issue":"2","key":"1677_CR18","doi-asserted-by":"publisher","DOI":"10.21926\/obm.geriatr.2002123","volume":"4","author":"Z Al-Mashhadi","year":"2020","unstructured":"Al-Mashhadi Z, Viggers R, Fuglsang-Nielsen R et al (2020) Bone health in the elderly with type 2 diabetes mellitus \u2013 a systematic review. OBM Geriatr 4(2):123. https:\/\/doi.org\/10.21926\/obm.geriatr.2002123","journal-title":"OBM Geriatr"},{"key":"1677_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-56127-w","volume":"14","author":"J Li","year":"2024","unstructured":"Li J, Zhou X, Wen J et al (2024) Establishment and validation of a nomogram clinical prediction model for osteoporosis in senile patients with type 2 diabetes mellitus. Sci Rep 14:5343. https:\/\/doi.org\/10.1038\/s41598-024-56127-w","journal-title":"Sci Rep"},{"key":"1677_CR20","unstructured":"Shah A, Hashmi MF, Aeddula NR (2024) Chronic Kidney Disease-Mineral Bone Disorder (CKD-MBD). StatPearls.\u00a0https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK560742\/. Accessed 17 Feb 2026"},{"key":"1677_CR21","unstructured":"Bone disease in diabetes mellitus. UpToDate. Available at: https:\/\/www.uptodate.com\/contents\/bone-disease-in-diabetes-mellitus. Accessed 17 Feb 2026"},{"issue":"3","key":"1677_CR22","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1056\/NEJMra070553","volume":"357","author":"MF Holick","year":"2007","unstructured":"Holick MF (2007) Vitamin D deficiency. N Engl J Med 357(3):266\u2013281. https:\/\/doi.org\/10.1056\/NEJMra070553","journal-title":"N Engl J Med"},{"issue":"1","key":"1677_CR23","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.pbiomolbio.2006.02.016","volume":"92","author":"P Lips","year":"2006","unstructured":"Lips P (2006) Vitamin D physiology. Prog Biophys Mol Biol 92(1):4\u20138. https:\/\/doi.org\/10.1016\/j.pbiomolbio.2006.02.016","journal-title":"Prog Biophys Mol Biol"},{"key":"1677_CR24","volume-title":"Dietary reference intakes for calcium and vitamin D","author":"Institute of Medicine","year":"2011","unstructured":"Institute of Medicine (2011) Dietary reference intakes for calcium and vitamin D. National Academies Press, Washington, DC"},{"key":"1677_CR25","unstructured":"International Osteoporosis Foundation. Key statistics for Europe. Available at: https:\/\/www.osteoporosis.foundation\/facts-statistics\/key-statistic-for-europe"},{"issue":"2","key":"1677_CR26","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00774-022-01393-2","volume":"41","author":"N Yoshimura","year":"2023","unstructured":"Yoshimura N et al (2023) Osteoporosis treatment initiation among Japanese patients hospitalized for osteoporotic fracture. J Bone Miner Metab 41(2):223\u2013230.https:\/\/doi.org\/10.1007\/s00774-022-01393-2. Accessed 17 Feb 2026","journal-title":"J Bone Miner Metab"},{"key":"1677_CR27","unstructured":"Curtis JR, et al (2021) Osteoporosis drug prescribing often does not follow guidelines. Endocrine News. Available at: https:\/\/www.endocrine.org\/news-and-advocacy\/news-room\/featured-science-from-endo-2021\/osteoporosis-drug-prescribing-often-does-not-follow-guidelines"},{"issue":"4","key":"1677_CR28","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/nrendo.2016.153","volume":"13","author":"N Napoli","year":"2017","unstructured":"Napoli N et al (2017) Bone health and fracture risk in diabetes mellitus. Nat Rev Endocrinol 13(4):208\u2013219. https:\/\/doi.org\/10.1038\/nrendo.2016.153. Accessed 17 Feb 2026","journal-title":"Nat Rev Endocrinol"}],"container-title":["Archives of Osteoporosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-026-01677-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11657-026-01677-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-026-01677-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T14:03:45Z","timestamp":1771941825000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11657-026-01677-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,24]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1677"],"URL":"https:\/\/doi.org\/10.1007\/s11657-026-01677-x","relation":{},"ISSN":["1862-3514"],"issn-type":[{"value":"1862-3514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,24]]},"assertion":[{"value":"1 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dilek Gogas Yavuz, Cem Haymana, Tolga Akkan, Muhiddin Yalcin, Zeliha Hekimsoy, Ilker Tasci, Mehmet Ali Eren, Naim Ata, Suayip Birinci, Alper Sonmez, Fahri Bayram declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest\/Disclosure"}}],"article-number":"41"}}